Virulence, phylogenetic background and antimicrobial resistance in Escherichia coli associated with extraintestinal infections.

Journal of Infection and Public Health
Katarína ČurováLeonard Siegfried

Abstract

Escherichia coli (E. coli) is a major cause of urinary tract infections and bloodstream infections and an important agent in the resistance to antibiotics. The present study sought to determine associations between virulence, phylogenetic background and antimicrobial resistance of E. coli strains isolated from patients with extraintestinal infections. A total of three hundred ten E. coli strains were isolated from blood, skin and soft tissue and urine. PCR methods were used to detect four main phylogenetic groups (A, B1, B2 and D) and 11 virulence genes (3 toxins, 3 adhesins, 1 siderophore, 4 capsule synthesis proteins and protectins). Standard broth microdilution test was used to determine sensitivity to 12 antimicrobial drugs. The most common and the most virulent phylogenetic group B2 was found in 193 (62.3%) isolates. The lowest virulence was observed among the group A. Analysis of virulence factors revealed the kpsMTII gene in 212 (68.4%), aer in 194 (62.6%) and tra in 184 (59.4%) of isolates, respectively. Multi-drug resistant (MDR) phenotype was noticed in 165 (53.2%) isolates. Lower representation of the MDR phenotype was detected in E. coli containing all groups of virulence genes and in the avirulent E. coli. Our stud...Continue Reading

References

Jan 1, 1991·Clinical Microbiology Reviews·J R Johnson
May 24, 2000·The Journal of Infectious Diseases·T A Russo, J R Johnson
Sep 30, 2000·Applied and Environmental Microbiology·O ClermontE Bingen
Mar 23, 2002·The Journal of Antimicrobial Chemotherapy·Rainer GattringerApostolos Georgopoulos
May 25, 2002·Cellular Microbiology·Matthew A Mulvey
Mar 26, 2004·Nature Reviews. Microbiology·James B KaperHarry L Mobley
Jun 12, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E BirosováL Valanský
Oct 6, 2006·Journal of Clinical Microbiology·Maryvonne Moulin-SchouleurJorge Blanco
May 17, 2008·Experimental and Molecular Pathology·Travis J WilesMatthew A Mulvey
Apr 10, 2009·Journal of Clinical Microbiology·Ziva PetkovsekMarjanca Starcic Erjavec
Feb 17, 2010·Nature Reviews. Microbiology·Olivier TenaillonErick Denamur
Apr 9, 2010·Journal of Clinical Microbiology·Damien DuboisRichard Bonnet
Oct 12, 2010·The Journal of Antimicrobial Chemotherapy·Laura VillaAlessandra Carattoli
Dec 9, 2010·Nature Reviews. Urology·Betsy Foxman
Jul 29, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A-P MagiorakosD L Monnet
Jan 31, 2012·Virulence·Gabriela Jorge Da Silva, Nuno Mendonça
May 1, 2013·Annals of Clinical Microbiology and Antimicrobials·Hassan MomtazNegar Souod
Sep 21, 2013·Emerging Infectious Diseases·Fahad AlhashashAlan McNally
Jun 5, 2014·BioMed Research International·Daniela A López-BandaRigoberto Hernández-Castro
Sep 28, 2015·The Journal of Infection·Adam P Dale, Neil Woodford
Nov 1, 2015·Journal of Medical Microbiology·Helen MiajlovicStephen Gj Smith

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.